drugset / Trial / NCT03362697

Lactobacillus Reuteri for Treatment of Uncomplicated UTI in Pregnant Women

NCT03362697

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Prevalence of uro-genital infections during pregnancy move between 7% to 12% in developed countries, meanwhile in developing countries this figure moved between 14% and until 55%, such is the case of Mexico. Meanwhile use of antibiotics for 3 to 7 days had established as a standard of care, the use of non-antibiotic therapy, such as cranberry powder or probiotics for prevention/treatment of this conditions is scarce. Randomized controlled trial aimed to evaluate the safety and efficacy of probiotic vs. antibiotics to treat pregnant women with uncomplicated cystitis or asymptomatic bacteriuria

Timeline

Start
2017-12-15
Primary completion
2018-12-30
Completion
2019-06-18

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified
Comparator Nitrofurantoin Unknown 200 mg Oral
Comparator clavulanic acid Small molecule